These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 29126907)

  • 1. Influence of cholesterol inclusion on the doxorubicin release characteristics of lysolipid-based thermosensitive liposomes.
    Sadeghi N; Deckers R; Ozbakir B; Akthar S; Kok RJ; Lammers T; Storm G
    Int J Pharm; 2018 Sep; 548(2):778-782. PubMed ID: 29126907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Materials characterization of the low temperature sensitive liposome (LTSL): effects of the lipid composition (lysolipid and DSPE-PEG2000) on the thermal transition and release of doxorubicin.
    Needham D; Park JY; Wright AM; Tong J
    Faraday Discuss; 2013; 161():515-34; discussion 563-89. PubMed ID: 23805756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The functional roles of poly(ethylene glycol)-lipid and lysolipid in the drug retention and release from lysolipid-containing thermosensitive liposomes in vitro and in vivo.
    Banno B; Ickenstein LM; Chiu GN; Bally MB; Thewalt J; Brief E; Wasan EK
    J Pharm Sci; 2010 May; 99(5):2295-308. PubMed ID: 19902527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The antitumor activity of tumor-homing peptide-modified thermosensitive liposomes containing doxorubicin on MCF-7/ADR: in vitro and in vivo.
    Wang C; Wang X; Zhong T; Zhao Y; Zhang WQ; Ren W; Huang D; Zhang S; Guo Y; Yao X; Tang YQ; Zhang X; Zhang Q
    Int J Nanomedicine; 2015; 10():2229-48. PubMed ID: 25834435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mild hyperthermia triggered doxorubicin release from optimized stealth thermosensitive liposomes improves intratumoral drug delivery and efficacy.
    Li L; ten Hagen TL; Hossann M; Süss R; van Rhoon GC; Eggermont AM; Haemmerich D; Koning GA
    J Control Release; 2013 Jun; 168(2):142-50. PubMed ID: 23524188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel temperature-triggered liposome with high stability: formulation, in vitro evaluation, and in vivo study combined with high-intensity focused ultrasound (HIFU).
    Park SM; Kim MS; Park SJ; Park ES; Choi KS; Kim YS; Kim HR
    J Control Release; 2013 Sep; 170(3):373-9. PubMed ID: 23770213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Engineering thermosensitive liposome-nanoparticle hybrids loaded with doxorubicin for heat-triggered drug release.
    Al-Ahmady Z; Lozano N; Mei KC; Al-Jamal WT; Kostarelos K
    Int J Pharm; 2016 Nov; 514(1):133-141. PubMed ID: 27863656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Method of hyperthermia and tumor size influence effectiveness of doxorubicin release from thermosensitive liposomes in experimental tumors.
    Willerding L; Limmer S; Hossann M; Zengerle A; Wachholz K; Ten Hagen TL; Koning GA; Sroka R; Lindner LH; Peller M
    J Control Release; 2016 Jan; 222():47-55. PubMed ID: 26658073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of liposomes and hyperthermia in a human tumor xenograft model: importance of triggered drug release.
    Kong G; Anyarambhatla G; Petros WP; Braun RD; Colvin OM; Needham D; Dewhirst MW
    Cancer Res; 2000 Dec; 60(24):6950-7. PubMed ID: 11156395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MRI Monitoring of Tumor-Selective Anticancer Drug Delivery with Stable Thermosensitive Liposomes Triggered by High-Intensity Focused Ultrasound.
    Kim HR; You DG; Park SJ; Choi KS; Um W; Kim JH; Park JH; Kim YS
    Mol Pharm; 2016 May; 13(5):1528-39. PubMed ID: 26998616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of lipid segregation and lysolipid dissociation on drug release from thermosensitive liposomes.
    Sandström MC; Ickenstein LM; Mayer LD; Edwards K
    J Control Release; 2005 Sep; 107(1):131-42. PubMed ID: 16023753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thermosensitive liposomes for triggered release of cytotoxic proteins.
    de Matos MBC; Beztsinna N; Heyder C; Fens MHAM; Mastrobattista E; Schiffelers RM; Leneweit G; Kok RJ
    Eur J Pharm Biopharm; 2018 Nov; 132():211-221. PubMed ID: 30223028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Motion Compensated Ultrasound Imaging Allows Thermometry and Image Guided Drug Delivery Monitoring from Echogenic Liposomes.
    Ektate K; Kapoor A; Maples D; Tuysuzoglu A; VanOsdol J; Ramasami S; Ranjan A
    Theranostics; 2016; 6(11):1963-74. PubMed ID: 27570563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of a passive equilibration methodology to encapsulate cisplatin into preformed thermosensitive liposomes.
    Woo J; Chiu GN; Karlsson G; Wasan E; Ickenstein L; Edwards K; Bally MB
    Int J Pharm; 2008 Feb; 349(1-2):38-46. PubMed ID: 17728083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formation of protein corona in vivo affects drug release from temperature-sensitive liposomes.
    Al-Ahmady ZS; Hadjidemetriou M; Gubbins J; Kostarelos K
    J Control Release; 2018 Apr; 276():157-167. PubMed ID: 29522832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A thermosensitive liposome prepared with a Cu²⁺ gradient demonstrates improved pharmacokinetics, drug delivery and antitumor efficacy.
    Tagami T; May JP; Ernsting MJ; Li SD
    J Control Release; 2012 Jul; 161(1):142-9. PubMed ID: 22504351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficient tumor regression by a single and low dose treatment with a novel and enhanced formulation of thermosensitive liposomal doxorubicin.
    Tagami T; Ernsting MJ; Li SD
    J Control Release; 2011 Jun; 152(2):303-9. PubMed ID: 21338635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and characterisation of ultrasound imageable heat-sensitive liposomes for HIFU therapy.
    Maples D; McLean K; Sahoo K; Newhardt R; Venkatesan P; Wood B; Ranjan A
    Int J Hyperthermia; 2015; 31(6):674-85. PubMed ID: 26185910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thermosensitive liposomes with higher phase transition temperature for targeted drug delivery to tumor.
    Chen J; He CQ; Lin AH; Gu W; Chen ZP; Li W; Cai BC
    Int J Pharm; 2014 Nov; 475(1-2):408-15. PubMed ID: 25218394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Magnetic resonance imaging of temperature-sensitive liposome release: drug dose painting and antitumor effects.
    Ponce AM; Viglianti BL; Yu D; Yarmolenko PS; Michelich CR; Woo J; Bally MB; Dewhirst MW
    J Natl Cancer Inst; 2007 Jan; 99(1):53-63. PubMed ID: 17202113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.